Published on
September 24, 2025
- 16:00 GMT
RhythmScience Licenses Groundbreaking AI Algorithm from Cedars-Sinai to Optimize Heart Failure Treatment
SAN FRANCISCO, CA, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- RhythmScience, a leader in cardiac data management solutions, today announced it has licensed the exclusive rights to the innovative heart failure –artificial intelligence (HF-AI) …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
